Suchergebnisse - "Faure, Frédéric"

PubPharm (63)

1

Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia : A national, randomized multicenter trial

enthalten in: Journal of internal medicine | 2023

von Dupuis-Girod, S. | Rivière, S. | Lavigne, C. | +23

2

Detection dogs as a help in the detection of COVID-19 Can the dog alert on COVID-19 positive persons by sniffing axillary sweat samples ? Proof-of-concept study

enthalten in: bioRxiv.org | 2023

von Grandjean, D. | Sarkis, R. | Tourtier, J. | +58

3

Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia : A national, randomized multicenter trial

enthalten in: Journal of Internal Medicine | 2023

von Dupuis‐Girod, S. | Rivière, S. | Lavigne, C. | +23

4

A New Animal Model of Laryngeal Transplantation

enthalten in: Journal of clinical medicine | 2022

von Philouze, P. | Malard, O. | Albert, S. | +11

5

Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire : An International Consensus

enthalten in: The Laryngoscope | 2022

von Buchholzer, S. | Faure, F. | Tcheremissinoff, L. | +32

6

Novel Multidisciplinary Salivary Gland Society ( MSGS) Questionnaire : An International Consensus

enthalten in: The Laryngoscope | 2022

von Buchholzer, S. | Faure, F. | Tcheremissinoff, L. | +32

7

The RAI-6 Questionnaire : A New Screening Questionnaire to Monitor Complications of Radioiodine Treatment

enthalten in: Frontiers in surgery | 2021

von Buchholzer, S. | Thakachy Subha, S. | Tchérémissinoff, L. | +9

8

Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer : American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology

enthalten in: Head & neck | 2020

von Singer, M. | Marchal, F. | Angelos, P. | +25

9

Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von Abergel, A. | Asselah, T. | Mallat, A. | +19

10

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia : A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial

enthalten in: Journal of clinical medicine | 2020

von Dupuis-Girod, S. | Fargeton, A. | Grobost, V. | +10

1
2
3
4
5
6
7
Nächster »
[7]